Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

Giovanni Scambia, Antonio Gonzalez-Martin, Laurence Gladieff, Bengt Tholander, Daniel Stroyakovsky, Martin Gore, Nadezhda Kovalenko, Ana Oaknin, Julian Perez Ronco, Ulrich Freudensprung, Sandro Pignata

Risultato della ricerca: Contributo in rivistaArticolo in rivista

34 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer'. Insieme formano una fingerprint unica.

Medicine & Life Sciences